Radiolabelled <sup>177</sup>Lu‐Bispidine‐Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Patrick A. Cieslik, Simon Klingler, Mirja Nolff, Jason P. Holland

Journal title: Chemistry – A European Journal

Journal number: 30

Journal publisher: John Wiley & Sons Ltd.

Published year: 2024

DOI identifier: 10.1002/chem.202303805

ISSN: 0947-6539